Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Functional in vivo imaging of cysteine cathepsin activity in murine model of inflammation.

Caglič D, Globisch A, Kindermann M, Lim NH, Jeske V, Juretschke HP, Bartnik E, Weithmann KU, Nagase H, Turk B, Wendt KU.

Bioorg Med Chem. 2011 Feb 1;19(3):1055-61. doi: 10.1016/j.bmc.2010.10.028. Epub 2010 Oct 19.

PMID:
21130662
2.

Carbobenzoxy-capped Phe-Lys(BODIPY TMR-X-acyloxymethyl ketone(QSY7).

Shan L.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2010 May 19 [updated 2010 May 25].

3.

Carbobenzoxy-capped Phe-Lys(Cy5)-acyloxymethyl ketone.

Shan L.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2010 May 9 [updated 2010 May 25].

4.

Design, characterization and cellular uptake studies of fluorescence-labeled prototypic cathepsin inhibitors.

Kohl F, Schmitz J, Furtmann N, Schulz-Fincke AC, Mertens MD, Küppers J, Benkhoff M, Tobiasch E, Bartz U, Bajorath J, Stirnberg M, Gütschow M.

Org Biomol Chem. 2015 Nov 7;13(41):10310-23. doi: 10.1039/c5ob01613d.

PMID:
26307943
5.

Selective targeting of lysosomal cysteine proteases with radiolabeled electrophilic substrate analogs.

Bogyo M, Verhelst S, Bellingard-Dubouchaud V, Toba S, Greenbaum D.

Chem Biol. 2000 Jan;7(1):27-38.

PMID:
10662686
6.

Noninvasive quantitative tomography of the therapeutic response to dexamethasone in ovalbumin-induced murine asthma.

Korideck H, Peterson JD.

J Pharmacol Exp Ther. 2009 Jun;329(3):882-9. doi: 10.1124/jpet.108.147579. Epub 2009 Mar 17.

7.

Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes.

Blum G, von Degenfeld G, Merchant MJ, Blau HM, Bogyo M.

Nat Chem Biol. 2007 Oct;3(10):668-77. Epub 2007 Sep 9.

PMID:
17828252
8.

Improved quenched fluorescent probe for imaging of cysteine cathepsin activity.

Verdoes M, Oresic Bender K, Segal E, van der Linden WA, Syed S, Withana NP, Sanman LE, Bogyo M.

J Am Chem Soc. 2013 Oct 2;135(39):14726-30. doi: 10.1021/ja4056068. Epub 2013 Sep 19.

9.
10.

Cathepsins X and B display distinct activity profiles that can be exploited for inhibitor design.

Ménard R, Therrien C, Lachance P, Sulea T, Qo H, Alvarez-Hernandez AD, Roush WR.

Biol Chem. 2001 May;382(5):839-45.

PMID:
11517939
11.

The consequences of lysosomotropism on the design of selective cathepsin K inhibitors.

Black WC, Percival MD.

Chembiochem. 2006 Oct;7(10):1525-35. Review.

PMID:
16921579
12.

Cysteine cathepsin proteases as pharmacological targets in cancer.

Palermo C, Joyce JA.

Trends Pharmacol Sci. 2008 Jan;29(1):22-8. Epub 2007 Nov 26. Review.

PMID:
18037508
13.

An activity-based probe for the determination of cysteine cathepsin protease activities in whole cells.

Falgueyret JP, Black WC, Cromlish W, Desmarais S, Lamontagne S, Mellon C, Riendeau D, Rodan S, Tawa P, Wesolowski G, Bass KE, Venkatraman S, Percival MD.

Anal Biochem. 2004 Dec 15;335(2):218-27. Erratum in: Anal Biochem. 2005 May 15;340(2):380.

PMID:
15556560
14.

In vivo imaging of intraperitoneally disseminated tumors in model mice by using activatable fluorescent small-molecular probes for activity of cathepsins.

Fujii T, Kamiya M, Urano Y.

Bioconjug Chem. 2014 Oct 15;25(10):1838-46. doi: 10.1021/bc5003289. Epub 2014 Sep 19.

PMID:
25196809
15.

Inhibition of the cathepsin cysteine proteases B and K by square-planar cycloaurated gold(III) compounds and investigation of their anti-cancer activity.

Zhu Y, Cameron BR, Mosi R, Anastassov V, Cox J, Qin L, Santucci Z, Metz M, Skerlj RT, Fricker SP.

J Inorg Biochem. 2011 May;105(5):754-62. doi: 10.1016/j.jinorgbio.2011.01.012. Epub 2011 Jan 26.

PMID:
21481817
16.

Imbalance between cysteine proteases and inhibitors in a baboon model of bronchopulmonary dysplasia.

Altiok O, Yasumatsu R, Bingol-Karakoc G, Riese RJ, Stahlman MT, Dwyer W, Pierce RA, Bromme D, Weber E, Cataltepe S.

Am J Respir Crit Care Med. 2006 Feb 1;173(3):318-26. Epub 2005 Sep 15.

17.

Cysteine cathepsins in human carious dentin.

Nascimento FD, Minciotti CL, Geraldeli S, Carrilho MR, Pashley DH, Tay FR, Nader HB, Salo T, Tjäderhane L, Tersariol IL.

J Dent Res. 2011 Apr;90(4):506-11. doi: 10.1177/0022034510391906. Epub 2011 Jan 19.

18.

In vivo detection of macrophage recruitment in hind-limb ischemia using a targeted near-infrared fluorophore.

Yoo JS, Das RK, Jow ZY, Chang YT.

PLoS One. 2014 Jul 29;9(7):e103721. doi: 10.1371/journal.pone.0103721. eCollection 2014.

19.

The medicinal chemistry of the cathepsin cysteine proteases.

Masuya K, Teno N.

Curr Top Med Chem. 2010;10(7):695. No abstract available.

PMID:
20392199
20.

Non-invasive imaging of cysteine cathepsin activity in solid tumors using a 64Cu-labeled activity-based probe.

Ren G, Blum G, Verdoes M, Liu H, Syed S, Edgington LE, Gheysens O, Miao Z, Jiang H, Gambhir SS, Bogyo M, Cheng Z.

PLoS One. 2011;6(11):e28029. doi: 10.1371/journal.pone.0028029. Epub 2011 Nov 21.

Supplemental Content

Support Center